Butylscopolamine | |
---|---|
Molecular structure via molpic based on CDK |
Rotamer [] | |
---|---|
Physical properties [] | |
---|---|
Molecular mass | 360.5 g/mol [1] |
Predicted LogP | 2.6 [1] |
Structural Identifiers [] | |
---|---|
Molecular formula | C21H30NO4+ [1] |
IUPAC name | [(1S,2S,4R,5R)-9-butyl-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate [1] |
SMILES | CCCC[N+]1([C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4)C [1] |
InChI | InChI=1S/C21H30NO4/c1-3-4-10-22(2)17-11-15(12-18(22)20-19(17)26-20)25-21(24)16(13-23)14-8-6-5-7-9-14/h5-9,15-20,23H,3-4,10-13H2,1-2H3/q+1/t15?,16-,17-,18+,19-,20+,22?/m1/s1 [1] |
InChIKey | YBCNXCRZPWQOBR-MWGADRMYSA-N [1] |
Dosing [] | |
---|---|
Elimination half-life | 5 hours |
Butylscopolamine
Butylscopolamine (also known as n-butylscopolammonium, N-butylscopolammonium ion, N-butylscopolammonium cation, butylscopolammonium, butilescopolamina, (7(S)-(1α,2β,4β,5α,7β))-9-Butyl-7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9-methyl-3-oxa-9-azonitricyclo(3.3.1.0(2,4))nonane, 3-Oxa-9-azonitricyclo(3.3.1.0(2,4))nonane, 9-butyl-7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9-methyl-, (7(S)-(1α,2β,4β,5α,7β))-, (2R,4S,5S,7s)-9-butyl-7-(((2S)-3-hydroxy-2-phenylpropanoyl)oxy)-9-methyl-3-oxa-9-azoniatricyclo(3.3.1.0(2,4))nonane, (2R,4S,5S,7s)-9-butyl-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.0(2,4)]nonane or Scopolamine N-N-Butyl) is a anticholinergic substance of the tropane class.
Chemistry
Stereochemistry []
Butylscopolamine is a absolute mixture
Anodyne Usernotes [] | |
---|---|
0xea / Butylscopolamine[hydrobromide] via Oral | dry mouth |
Legal status
- Australia: Butylscopolamine is a S2 substance.[3]
- Canada: Butylscopolamine is a OTC (Pharmacist only) substance.
- United Kingdom: Butylscopolamine is a GSL substance.
- United States: Butylscopolamine is a prescription only substance.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 160883, Butylscopolamine. Accessed September 14, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/160883
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Butylscopolamine. UNII: 2Z3E1OF81V. Global Substance Registration System. Accessed September 14, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/2Z3E1OF81V
Hyoscine Butylbromide (AFT Pharmaceuticals Pty Ltd). Accessed September 14, 2025. https://www.tga.gov.au/resources/prescription-medicines-registrations/hyoscine-butylbromide-aft-pharmaceuticals-pty-ltd